Fibrin Glue vs. Suture in Pterygium Surgery
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The use of Fibrin glue to place conjunctival graft will be as effective as suturing the graft, but will require much less operative time and will be better tolerated by the patients.
| Condition | Intervention |
|---|---|
|
Conjunctival Autograft |
Procedure: Fibrin Glue, Quixil Procedure: Suture |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Fibrin Glue vs. Vicryl Suture in Pterygium Surgery With Conjunctival Auto-graft |
- Pterygium recurrence [ Time Frame: one year ] [ Designated as safety issue: No ]Recurrence normally occurs 1-6 months after surgery. Success is achieved if ptergium does not recur after one year.
- operation time [ Time Frame: one year ] [ Designated as safety issue: No ]suturing a conjunctival graft takes 15-10 minutes while gluing only 5 minutes, we believe that by lowering OR time, total costs of surgery are less
| Estimated Enrollment: | 60 |
| Study Start Date: | January 2010 |
| Estimated Study Completion Date: | December 2012 |
| Estimated Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Fibrin Glue, surgery
Conjunctival autograft will be glued using fibrin glue to pterygia bed after removal
|
Procedure: Fibrin Glue, Quixil
quixil 0.1 ml
|
|
Active Comparator: Control
Conjunctival autograft will be sutured using 10/0 vicryl sutures to pterygia bed after removal
|
Procedure: Suture
vicryl 10/0
|
Detailed Description:
Pterygium surgery requires removal of the pterygia from cornea and conjunctiva and an additional technique to prevent recurrence which may be as high as 50%.
Suturing a conjunctival auto-graft has become one of the most popular and effective methods in preventing recurrence. However suturing requires long operative time (10-20 minutes with removal alone less than 5 minutes) and requires sutures removal after 1-2 weeks which is very inconvenient to the patient.
Using Fibrin Glue (Quixil) has been used in several places in pterygium surgery and we believe it will be as effective as suturing the graft, will use much less OR time (reduce surgery time from 40 minutes to 20-25 minutes) and will be less expensive since 2 ml glue (around 80US$) suffice for 10 cases, while one vicryl suture costs around 34 US$.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- primary pterygium
- healthy subject
- ability to attend follow-up visits
Exclusion Criteria:
- recurrent pterygium
- underwent previous surgery / intervention to treat pterygium
- ocular surface disease 0 minor
Contacts and Locations| Contact: Guy J Ben Simon, MD | 972509716632 | guybensimon@gmail.com |
| Contact: Mordechai Rosner, MD | 972526667242 | Mordecai.Rosner@sheba.health.gov.il |
| Israel | |
| Sheba_Medical_Center | Recruiting |
| Ramat Gan, Israel, 52621 | |
| Contact: Guy J Ben Simon, MD 97235302874 guybensimon@gmail.com | |
| Contact: Mordechai Rosner, MD 972526667242 Mordecai.Rosner@sheba.health.gov.il | |
| Principal Investigator: Guy J Ben Simon, MD | |
| Sub-Investigator: Mordechai Rosner, MD | |
| Sub-Investigator: Nachum Rosen, MD | |
More Information
Publications:
| Responsible Party: | Guy J. Ben Simon, MD, Sheba Medical Center |
| ClinicalTrials.gov Identifier: | NCT01158014 History of Changes |
| Other Study ID Numbers: | SHEBA-09-5033-GB-CTIL |
| Study First Received: | July 4, 2010 |
| Last Updated: | July 8, 2010 |
| Health Authority: | Israel: Israeli Health Ministry Pharmaceutical Administration |
Keywords provided by Sheba Medical Center:
|
pterygium conjunctival graft recurrence primary pterygium |
Additional relevant MeSH terms:
|
Pterygium Conjunctival Diseases Eye Diseases Fibrin Tissue Adhesive Hemostatics |
Coagulants Hematologic Agents Therapeutic Uses Pharmacologic Actions |
ClinicalTrials.gov processed this record on May 19, 2013